Human ether-à-go-go gene potassium channels are regulated by EGFR tyrosine kinase

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 2, 2012, Pages 282-289

  Wu, Wei ^a   Dong, Ming Qing ^a   Wu, Xing Gang ^a   Sun, Hai Ying ^a   Tse, Hung Fat ^a   Lau, Chu Pak ^a   Li, Gui Rong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

EGFR kinase; Ion channel modulation; Protein tyrosine kinase; Protein tyrosine phosphorylation; Signal transduction

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 6,7 DIMETHYL 2 PHENYLQUINOXALINE; ALANINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; N (4 BUTYLPHENYL) ALPHA CYANOCAFFEIC ACID AMIDE; ORTHOVANADIC ACID; POTASSIUM CHANNEL HERG; SMALL INTERFERING RNA; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL STRAIN HEK293; CONTROLLED STUDY; IMMUNOPRECIPITATION; NERVE CELL; NERVE CELL EXCITABILITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; WESTERN BLOTTING;

ETHER-A-GO-GO POTASSIUM CHANNELS; HEK293 CELLS; HUMANS; PATCH-CLAMP TECHNIQUES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TYROSINE; TYRPHOSTINS; VANADATES;

EID: 84862802638     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.10.010     Document Type: Article

References (45)

1. 2+ and modulated by cAMP. Nature 1993, 365:445-448.
2. Ludwig J., Terlau H., Wunder F., Bruggemann A., Pardo L.A., Marquardt A., Stuhmer W., Pongs O. Functional expression of a rat homologue of the voltage gated either a go-go potassium channel reveals differences in selectivity and activation kinetics between the Drosophila channel and its mammalian counterpart. EMBO J. 1994, 13:4451-4458.
3. Farias L.M., Ocana D.B., Diaz L., Larrea F., Avila-Chavez E., Cadena A., Hinojosa L.M., Lara G., Villanueva L.A., Vargas C., Hernandez-Gallegos E., Camacho-Arroyo I., Duenas-Gonzalez A., Perez-Cardenas E., Pardo L.A., Morales A., Taja-Chayeb L., Escamilla J., Sanchez-Pena C., Camacho J. Ether a go-go potassium channels as human cervical cancer markers. Cancer Res. 2004, 64:6996-7001.
4. Hemmerlein B., Weseloh R.M., Mello de Queiroz F., Knotgen H., Sanchez A., Rubio M.E., Martin S., Schliephacke T., Jenke M., Heinz Joachim R., Stuhmer W., Pardo L.A. Overexpression of Eag1 potassium channels in clinical tumours. Mol. Cancer 2006, 5:41.
5. Mello de Queiroz F., Suarez-Kurtz G., Stuhmer W., Pardo L.A. Ether a go-go potassium channel expression in soft tissue sarcoma patients. Mol. Cancer 2006, 5:42.
6. Pardo L.A., Contreras-Jurado C., Zientkowska M., Alves F., Stuhmer W. Role of voltage-gated potassium channels in cancer. J. Membr. Biol. 2005, 205:115-124.
7. + channels in brain. J. Neurosci. 2001, 21:4609-4624.
8. Weber C., Mello de Queiroz F., Downie B.R., Suckow A., Stuhmer W., Pardo L.A. Silencing the activity and proliferative properties of the human EagI potassium channel by RNA interference. J. Biol. Chem. 2006, 281:13030-13037.
9. Gavrilova-Ruch O., Schonherr R., Heinemann S.H. Activation of hEAG1 potassium channels by arachidonic acid. Pflugers Arch. 2007, 453:891-903.
10. Schonherr R., Lober K., Heinemann S.H. Inhibition of human ether a go-go potassium channels by Ca(2+)/calmodulin. EMBO J. 2000, 19:3263-3271.
11. 2+/calmodulin binding to the cytosolic N- and C-termini. FEBS J. 2006, 273:1074-1086.
12. Wang Z., Wilson G.F., Griffith L.C. Calcium/calmodulin-dependent protein kinase II phosphorylates and regulates the Drosophila eag potassium channel. J. Biol. Chem. 2002, 277:24022-24029.
13. Marble D.D., Hegle A.P., Snyder E.D., Dimitratos S., Bryant P.J., Wilson G.F. Camguk/CASK enhances Ether-a-go-go potassium current by a phosphorylation-dependent mechanism. J. Neurosci. 2005, 25:4898-4907.
14. Hubbard S.R., Till J.H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 2000, 69:373-398.
15. Hunter T. Signaling-2000 and beyond. Cell 2000, 100:113-127.
16. Davis M.J., Wu X., Nurkiewicz T.R., Kawasaki J., Gui P., Hill M.A., Wilson E. Regulation of ion channels by protein tyrosine phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:H1835-H1862.
17. Levitan I.B. Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu. Rev. Physiol. 1994, 56:193-212.
18. Dong M.Q., Sun H.Y., Tang Q., Tse H.F., Lau C.P., Li G.R. Regulation of human cardiac KCNQ1/KCNE1 channel by epidermal growth factor receptor kinase. Biochim. Biophys. Acta 2010, 1798:995-1001.
19. Zhang D.Y., Wang Y., Lau C.P., Tse H.F., Li G.R. Both EGFR kinase and Src-related tyrosine kinases regulate human ether-a-go-go-related gene potassium channels. Cell. Signal. 2008, 20:1815-1821.
20. Zhang D.Y., Zhang Y.H., Sun H.Y., Lau C.P., Li G.R. Epidermal growth factor receptor tyrosine kinase regulates the human inward rectifier potassium channel Kir2.3 stably expressed in HEK 293 cells. Br. J. Pharmacol. 2011, 164:1469-1478.
21. Zhang D.Y., Wei W., Deng X.L., Lau C.P., Li G.R. Biochimica et Biophysica Acta (BBA) - Biomembranes 2011, 1808:1993-1999.
22. Liu H., Sun H.Y., Lau C.P., Li G.R. Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes. J. Mol. Cell. Cardiol. 2007, 42:760-768.
23. Du X.L., Gao Z., Lau C.P., Chiu S.W., Tse H.F., Baumgarten C.M., Li G.R. Differential effects of tyrosine kinase inhibitors on volume-sensitive chloride current in human atrial myocytes: evidence for dual regulation by Src and EGFR kinases. J. Gen. Physiol. 2004, 123:427-439.
24. Dong M.Q., Lau C.P., Gao Z., Tseng G.N., Li G.R. Characterization of recombinant human cardiac KCNQ1/KCNE1 channels (I (Ks)) stably expressed in HEK 293 cells. J. Membr. Biol. 2006, 210:183-192.
25. Tang Q., Jin M.W., Xiang J.Z., Dong M.Q., Sun H.Y., Lau C.P., Li G.R. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells. Biochem. Pharmacol. 2007, 74:1596-1607.
26. Gazit A., Osherov N., Posner I., Yaish P., Poradosu E., Gilon C., Levitzki A. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J. Med. Chem. 1991, 34:1896-1907.
27. Kovalenko M., Gazit A., Bohmer A., Rorsman C., Ronnstrand L., Heldin C.H., Waltenberger J., Bohmer F.D., Levitzki A. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 1994, 54:6106-6114.
28. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 1996, 271:695-701.
29. Stansfeld C.E., Roper J., Ludwig J., Weseloh R.M., Marsh S.J., Brown D.A., Pongs O. Elevation of intracellular calcium by muscarinic receptor activation induces a block of voltage-activated rat ether-a-go-go channels in a stably transfected cell line. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9910-9914.
30. Schonherr R., Hehl S., Terlau H., Baumann A., Heinemann S.H. Individual subunits contribute independently to slow gating of bovine EAG potassium channels. J. Biol. Chem. 1999, 274:5362-5369.
31. Li G.R., Sun H., Deng X., Lau C.P. Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells 2005, 23:371-382.
32. Kramer H.K., Onoprishvili I., Andria M.L., Hanna K., Sheinkman K., Haddad L.B., Simon E.J. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases. BMC Pharmacol. 2002, 2:5.
33. Fanger C.M., Ghanshani S., Logsdon N.J., Rauer H., Kalman K., Zhou J., Beckingham K., Chandy K.G., Cahalan M.D., Aiyar J. Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J. Biol. Chem. 1999, 274:5746-5754.
34. Gao Z., Lau C.P., Wong T.M., Li G.R. Protein tyrosine kinase-dependent modulation of voltage-dependent potassium channels by genistein in rat cardiac ventricular myocytes. Cell. Signal. 2004, 16:333-341.
35. + current in guinea-pig ventricular myocytes. J. Physiol. 2006, 573:469-482.
36. Tiran Z., Peretz A., Attali B., Elson A. Phosphorylation-dependent regulation of Kv2.1 Channel activity at tyrosine 124 by Src and by protein-tyrosine phosphatase epsilon. J. Biol. Chem. 2003, 278:17509-17514.
37. 2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation. Am. J. Physiol. 1999, 276:H1724-H1733.
38. Wijetunge S., Lymn J.S., Hughes A.D. Effect of inhibition of tyrosine phosphatases on voltage-operated calcium channel currents in rabbit isolated ear artery cells. Br. J. Pharmacol. 1998, 124:307-316.
39. Lepple-Wienhues A., Szabo I., Wieland U., Heil L., Gulbins E., Lang F. Tyrosine kinases open lymphocyte chloride channels. Cell. Physiol. Biochem. 2000, 10:307-312.
40. Missan S., Qi J., Crack J., McDonald T.F., Linsdell P. Regulation of wild-type and mutant KCNQ1/KCNE1 channels by tyrosine kinase. Pflugers Arch. 2009, 458:471-480.
41. - current in rabbit ventricle by Src and EGFR protein tyrosine kinases. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2628-H2636.
42. Gomez-Varela D., Zwick-Wallasch E., Knotgen H., Sanchez A., Hettmann T., Ossipov D., Weseloh R., Contreras-Jurado C., Rothe M., Stuhmer W., Pardo L.A. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res. 2007, 67:7343-7349.
43. Huang S., Armstrong E.A., Benavente S., Chinnaiyan P., Harari P.M. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res. 2004, 64:5355-5362.
44. Li J., Li Y., Feng Z.Q., Chen X.G. Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo. Cancer Lett. 2009, 279:213-220.
45. Okabe T., Okamoto I., Tsukioka S., Uchida J., Iwasa T., Yoshida T., Hatashita E., Yamada Y., Satoh T., Tamura K., Fukuoka M., Nakagawa K. Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase. Mol. Cancer Ther. 2008, 7:599-606.